These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31211324)

  • 21. [Digoxin: the results of the DIG study in the XXI century].
    Helber I; Tucci PJ
    Arq Bras Cardiol; 2010 Oct; 95(4):e108-11. PubMed ID: 21180781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of age on mortality, hospitalizations and response to digoxin in patients with heart failure: the DIG study.
    Rich MW; McSherry F; Williford WO; Yusuf S;
    J Am Coll Cardiol; 2001 Sep; 38(3):806-13. PubMed ID: 11527638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Digitalis, a drug to be scrapped?].
    Cosmi F; Tarquini B; Mariottoni B; Cosmi D
    G Ital Cardiol (Rome); 2017 Feb; 18(2):121-128. PubMed ID: 28398365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential effects of digoxin on long-term renal and clinical outcomes in chronic heart failure.
    Testani JM; Brisco MA; Tang WH; Kimmel SE; Tiku-Owens A; Forfia PR; Coca SG
    J Card Fail; 2013 May; 19(5):295-302. PubMed ID: 23663810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin and mortality in chronic heart failure. UK Heart Investigation.
    Lindsay SJ; Kearney MT; Prescott RJ; Fox KA; Nolan J
    Lancet; 1999 Sep; 354(9183):1003. PubMed ID: 10501370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.
    Hashim T; Elbaz S; Patel K; Morgan CJ; Fonarow GC; Fleg JL; McGwin G; Cutter GR; Allman RM; Prabhu SD; Zile MR; Bourge RC; Ahmed A
    Am J Med; 2014 Feb; 127(2):132-9. PubMed ID: 24067296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digoxin therapy does not improve outcomes in patients with advanced heart failure on contemporary medical therapy.
    Georgiopoulou VV; Kalogeropoulos AP; Giamouzis G; Agha SA; Rashad MA; Waheed S; Laskar S; Smith AL; Butler J
    Circ Heart Fail; 2009 Mar; 2(2):90-7. PubMed ID: 19808323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial.
    Shlipak MG; Smith GL; Rathore SS; Massie BM; Krumholz HM
    J Am Soc Nephrol; 2004 Aug; 15(8):2195-203. PubMed ID: 15284305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data.
    Ziff OJ; Lane DA; Samra M; Griffith M; Kirchhof P; Lip GY; Steeds RP; Townend J; Kotecha D
    BMJ; 2015 Aug; 351():h4451. PubMed ID: 26321114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overview of the DIG trial.
    Collins JF; Egan D; Yusuf S; Garg R; Williford WO; Geller N;
    Control Clin Trials; 2003 Dec; 24(6 Suppl):269S-276S. PubMed ID: 14643073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with mild heart failure worsen during withdrawal from digoxin therapy.
    Adams KF; Gheorghiade M; Uretsky BF; Young JB; Ahmed S; Tomasko L; Packer M
    J Am Coll Cardiol; 1997 Jul; 30(1):42-8. PubMed ID: 9207619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The place of cardiac glycosides in the treatment of chronic heart failure. Part III. The DIG trial].
    Sidorenko BA; Preobrazhenskiĭ DV; Sharoshina IA; Batyraliev TA; Pershukov IV; Makhmutkhodzhaev SA
    Kardiologiia; 2005; 45(6):61-70. PubMed ID: 16007036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose response characterization of the association of serum digoxin concentration with mortality outcomes in the Digitalis Investigation Group trial.
    Adams KF; Butler J; Patterson JH; Gattis Stough W; Bauman JL; van Veldhuisen DJ; Schwartz TA; Sabbah H; Mackowiak JI; Ventura HO; Ghali JK
    Eur J Heart Fail; 2016 Aug; 18(8):1072-81. PubMed ID: 27492641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure.
    Control Clin Trials; 1996 Feb; 17(1):77-97. PubMed ID: 8721804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of digoxin at low serum concentrations on mortality and hospitalization in heart failure: a propensity-matched study of the DIG trial.
    Ahmed A; Pitt B; Rahimtoola SH; Waagstein F; White M; Love TE; Braunwald E
    Int J Cardiol; 2008 Jan; 123(2):138-46. PubMed ID: 17382417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Addition of beta-blockers to digoxin is associated with improved 1- and 10-year survival of patients hospitalized due to decompensated heart failure.
    Katz A; Maor E; Leor J; Klempfner R
    Int J Cardiol; 2016 Oct; 221():198-204. PubMed ID: 27404675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of digitalis on mortality in a large cohort of implantable cardioverter defibrillator recipients: results of a long-term follow-up study in 1020 patients.
    Erath JW; Vamos M; Hohnloser SH
    Eur Heart J Cardiovasc Pharmacother; 2016 Jul; 2(3):168-74. PubMed ID: 27533758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Use of Digitalis: A State of the Art Review.
    Whayne TF
    Am J Cardiovasc Drugs; 2018 Dec; 18(6):427-440. PubMed ID: 30066080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whither digitalis?
    Campbell RW
    Lancet; 1997 Jun; 349(9069):1854-5. PubMed ID: 9217753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.